ADAR1 Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.65M Buy
+5,060
New +$5.13M 0.27% 81
2025
Q4
Sell
-1,000
Closed -$763K 283
2025
Q3
$763K Buy
1,000
+500
+100% +$372K 0.07% 111
2025
Q2
$390K Sell
500
-100
-17% -$77.7K 0.06% 128
2025
Q1
$496K Sell
600
-750
-56% -$624K 0.09% 104
2024
Q4
$1.04M Buy
1,350
+200
+17% +$166K 0.21% 74
2024
Q3
$1.02M Buy
+1,150
New +$1.03M 0.17% 77
2024
Q2
Sell
-1,865
Closed -$1.45M 300
2024
Q1
$1.45M Buy
+1,865
New +$1.33M 0.33% 53

Other funds holding LLY

ADAR1 Capital Management's LLY Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 5,060 shares worth $4.65M. The stake represents 0.27% of the portfolio and ranks #81 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in LLY as recently as Q3 2025.

ADAR1 Capital Management first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ADAR1 Capital Management held 5,060 shares of Eli Lilly worth $4.65M as of Q1 2026.
  • Eli Lilly was a new ADAR1 Capital Management position in Q1 2026.
  • Eli Lilly made up 0.27% of ADAR1 Capital Management's portfolio in Q1 2026, its #81 holding.
  • ADAR1 Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.